About Lepure Biotech
Lepure Biotech is a company based in Shanghai (China) founded in 2011. Lepure Biotech has raised $15.22 million across 3 funding rounds from investors including General Atlantic, Huimei Healthcare and Novo Holdings. Lepure Biotech offers products and services including Single-Use Systems and Filtration Systems.
- Headquarter Shanghai, China
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Shanghai Lepure Biotech Co., Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$15.22 M (USD)
in 3 rounds
-
Latest Funding Round
-
Investors
General Atlantic
& 16 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lepure Biotech
Lepure Biotech offers a comprehensive portfolio of products and services, including Single-Use Systems and Filtration Systems.
Single-use systems are utilized for fluid management and storage in biopharmaceutical production processes.
Filtration and purification solutions are employed for virus removal and sterilization in manufacturing applications.
Funding Insights of Lepure Biotech
Lepure Biotech has successfully raised a total of $15.22M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
-
First Round
First Round
(06 Apr 2021)
- Investors Count 17
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2023 | Amount | Series C - Lepure Biotech | Valuation | Novo Holdings , General Atlantic | |
| Nov, 2021 | Amount | Series B - Lepure Biotech | Valuation | Hillhouse , New Alliance Capital | |
| Apr, 2021 | Amount | Series B - Lepure Biotech | Valuation | Legend Capital |
|
Investors in Lepure Biotech
Lepure Biotech has secured backing from 17 investors, including venture fund and institutional investors. Prominent investors backing the company include General Atlantic, Huimei Healthcare and Novo Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital fund focused on the healthcare sector
|
Founded Year | Domain | Location | |
|
Private equity fund focused on global markets
|
Founded Year | Domain | Location | |
|
Healthcare startups are funded by HLC venture capital firm.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Lepure Biotech
Financial Statements - Lepure Biotech
Lepure Biotech Comparisons
Competitors of Lepure Biotech
Latest news on Lepure Biotech
Frequently Asked Questions about Lepure Biotech
Lepure Biotech was founded in 2011 and raised its 1st funding round 10 years after it was founded.
Lepure Biotech is headquartered in Shanghai, China.
Wang Fengfrank is the current CEO of Lepure Biotech.
Lepure Biotech is a funded company, having raised a total of $15.22M across 3 funding rounds to date. The company's 1st funding round was a Series B of $15.22M, raised on Apr 06, 2021.
Lepure Biotech was established in 2011 in Shanghai, China. Operations focus on the biotech sector, where traditional packaging, dispensing, and storage solutions are supplied. Services include standard containers and systems for product handling and preservation. The company serves clients primarily in the Asian market, with leadership provided by CEO Wang Fengfrank. Domain lepure-bio.com is maintained for online presence.
Lepure Biotech offers Single-Use Systems and Filtration Systems.
Lepure Biotech has 17 investors. Key investors include General Atlantic, Huimei Healthcare, Novo Holdings, Honghui Fund, and Guangdong Zhongke Kechuang Venture Capital Management.